Enoxaparin Sodium Injection
Product Images NDC 25021-410

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 25021-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Eno0i 0002 01)

An instructional illustration showing two hands: one holding a syringe and the other holding a small cap, with arrows indicating the removal of the cap from the syringe before use.*

FDA Label Image

Figure (Eno0i 0002 02)

An instructional illustration demonstrating how to use an injection syringe containing enoxaparin sodium. It shows a hand holding the syringe with the other hand placed underneath, likely indicating the method to prepare or administer the injection subcutaneously.*

FDA Label Image

Figure (Eno0i 0002 03)

An instructional illustration showing a hand holding a syringe, administering a subcutaneous injection into the skin. The image depicts the action of injecting medication under the skin, relevant for subcutaneous injections such as Enoxaparin Sodium injection.*

FDA Label Image

Figure (Eno0i 0002 04)

An instructional illustration showing a hand holding a syringe with an arrow pointing upward, indicating the proper technique to remove air bubbles from an injection syringe. The image relates to subcutaneous injection procedures, consistent with Enoxaparin Sodium injection administration.*

FDA Label Image

Figure (Eno0i 0002 05)

An instructional illustration showing a hand discarding a syringe into a container labeled with a biohazard symbol, indicating safe disposal of medical sharps.*

FDA Label Image

Figure (Eno0i 0002 06)

Chemical structure diagram of Enoxaparin Sodium showing its repeating molecular units and variable substituents R1 and R2 as hydrogen, sodium sulfate, or acetyl groups.*

FDA Label Image

Figure (Eno0i 0002 07)

Chemical structure of Enoxaparin Sodium, illustrating its molecular composition including sodium, hydroxyl, and sulfate groups connected in a polysaccharide framework.*

FDA Label Image

Figure (Eno0i 0002 08)

A forest plot chart comparing the relative risk of various subgroups treated with Enoxaparin Sodium injection versus UFH. The chart includes patient subgroups based on sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent, time to treatment, and PCI within 30 days. Each subgroup shows relative risk values, percentage outcomes for UFH and Enoxaparin treatments, and the reduction in risk percentage. The plot visually indicates whether Enoxaparin or UFH is favored across subgroups.*

FDA Label Image

Figure (Eno0i 0002 09)

A hazard distribution function graph comparing Enoxaparin and UFH over time to death or myocardial re-infarction (days). The graph shows hazard curves for Enoxaparin and UFH patients with data points and includes a smaller inset graph depicting hazard distribution at one year. The bottom lists the number of patients at risk at various time points for both treatments. The title notes statistical significance with Log-Rank Test p-values.*

FDA Label Image

Figure (Eno0i 0002 10)

An instructional diagram illustrating the proper handling of a syringe before and after use. The 'Before Use' side labels the plunger rod, needle, and needle cap on the syringe. The 'After Use' side shows the plunger rod and the syringe with a protective sleeve covering the needle.*

FDA Label Image

Figure (Eno0i 0002 11)

An instructional diagram titled 'Figure A' showing components for Enoxaparin Sodium prefilled syringe administration. It includes a sharp disposal container, one cotton ball or gauze, one alcohol wipe, one small adhesive bandage, and the Enoxaparin Sodium prefilled syringe itself.*

FDA Label Image

Figure (Eno0i 0002 12)

An instructional illustration showing hands holding a prefilled syringe. One hand is peeling off a protective cover or adhesive strip from the syringe barrel while the other hand holds the syringe steady. The image likely demonstrates a step in preparing an Enoxaparin Sodium subcutaneous injection for administration.*

FDA Label Image

Figure (Eno0i 0002 13)

Illustration showing a syringe for injection labeled with an expiration date indicator on the barrel. The syringe is depicted with a plunger, barrel, and needle cover, highlighting where the expiration date is located on the device.*

FDA Label Image

Figure (Eno0i 0002 14)

An instructional illustration labeled Figure D showing a syringe filled with a clear liquid. The syringe has measurement markings and a plunger, indicating it is prepared for injection. No additional text or branding is visible.*

FDA Label Image

Figure (Eno0i 0002 15)

Illustration showing the recommended subcutaneous injection sites for Enoxaparin Sodium injection. The diagram highlights the left and right sides of the lower abdomen as appropriate areas for injection administration.*

FDA Label Image

Figure (Eno0i 0002 16)

An instructional diagram depicting a hand applying a small adhesive patch or dressing to the lower abdomen area of a person, likely illustrating an injection site for subcutaneous administration.*

FDA Label Image

Figure (Eno0i 0002 17)

An instructional line drawing showing two hands preparing a syringe. One hand holds a syringe with a visible plunger, while the other hand is pulling off a protective cap or cover from the needle. Arrows indicate the direction to pull the cap away from the needle to remove it.*

FDA Label Image

Figure (Eno0i 0002 18)

An instructional illustration showing a hand holding a syringe for Enoxaparin Sodium injection, demonstrating how to set the dose by adjusting the plunger. An arrow indicates pressing down to prepare the dose, with a label pointing to the dose setting on the syringe barrel.*

FDA Label Image

Figure (Eno0i 0002 19)

An instructional line drawing demonstrating a hand performing a subcutaneous injection technique, with the thumb and fingers pinching the skin to create a fold, likely illustrating the proper method for injecting Enoxaparin Sodium subcutaneously.*

FDA Label Image

Figure (Eno0i 0002 20)

An instructional illustration showing the proper technique for administering a subcutaneous injection of Enoxaparin Sodium. It depicts a hand holding a syringe inserted at a 90-degree angle into the subcutaneous tissue of the abdominal area, indicating the injection site and angle.*

FDA Label Image

Figure (Eno0i 0002 21)

An instructional illustration showing the subcutaneous injection of Enoxaparin Sodium. It depicts a hand administering the injection into the thigh area with a syringe, demonstrating correct injection technique for this dosage form.*

FDA Label Image

Figure (Eno0i 0002 22)

An instructional illustration showing a hand holding a syringe for subcutaneous injection of Enoxaparin Sodium. The diagram depicts the injection process with an arrow indicating the direction for administering the injection into the abdomen area.*

FDA Label Image

Figure (Eno0i 0002 23)

An instructional illustration showing a hand holding a syringe with a protective sleeve. The image indicates to push the syringe backward until a 'click' is heard, pointing to the proper handling technique for the injection device.*

FDA Label Image

Figure (Eno0i 0002 24)

An instructional illustration showing a hand holding an Enoxaparin Sodium injection syringe above a Sharps Disposal Container. The syringe and needle cap are labeled, demonstrating the proper disposal of the syringe into the container after use.*

FDA Label Image

Figure (Eno0i 0002 25)

Label for Enoxaparin Sodium Injection, USP 30 mg per 0.3 mL in a single-dose syringe with automatic safety device. The label indicates the injection is for subcutaneous use and contains information on storage temperature (20° to 25°C), dosage instructions, and manufacturer Sagent Pharmaceuticals. The syringe volume is 0.3 mL.*

FDA Label Image

Figure (Eno0i 0002 26)

Label for Enoxaparin Sodium Injection, USP 40 mg per 0.4 mL single-dose syringe. The label indicates it is for subcutaneous injection and includes dosage and storage instructions. The product is manufactured by Sagent Pharmaceuticals and features an automatic safety device syringe. The label shows NDC 25021-410-76 and cautions to store at 20° to 25°C and keep out of reach of children.*

FDA Label Image

Figure (Eno0i 0002 27)

Label for Enoxaparin Sodium Injection, USP, 60 mg per 0.6 mL, single-dose syringe with automatic safety device for subcutaneous injection. The label includes dosage information, storage instructions at controlled room temperature, and labeler Sagent Pharmaceuticals. It also shows the NDC 25021-410-77 and usage warnings.*

FDA Label Image

Figure (Eno0i 0002 28)

Label for Enoxaparin Sodium Injection, USP, 80 mg per 0.8 mL single-dose syringe with automatic safety device for subcutaneous injection. The label includes dosing and storage instructions, manufacturer Sagent Pharmaceuticals, and a barcode. It specifies the syringe volume is 0.8 mL.*

FDA Label Image

Figure (Eno0i 0002 29)

Label for Enoxaparin Sodium Injection, USP, 100 mg per mL in a single-dose 1 mL syringe by Sagent Pharmaceuticals. It indicates subcutaneous injection usage with dosage and administration information, storage instructions, and a safety warning. The label includes the NDC 25021-410-71 and batch details placeholder.*

FDA Label Image

Figure (Eno0i 0002 30)

Label for Enoxaparin Sodium Injection, USP showing a strength of 120 mg per 0.8 mL in a single-dose syringe for subcutaneous injection. The label indicates it is manufactured by Sagent Pharmaceuticals and includes storage instructions and a barcode. Additional details include dosage instructions and labeling for lot number and expiration date.*

FDA Label Image

Figure (Eno0i 0002 31)

Label for Enoxaparin Sodium Injection, USP 150 mg per mL in a single-dose, 1 mL syringe with automatic safety device for subcutaneous injection. Label shows manufacturer as Sagent Pharmaceuticals and includes dosage and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.